Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure

Pediatric Nephrology

Volumn 21, Issue 2, 2006, Pages 239-245

  Ece, Aydin ^a   Atamer, Yildiz ^a   Gürkan, Fuat ^a   Davutoǧlu, Mehmet ^b   Bilici, Meki ^c   Tutanç, Murat ^a   Güneş, Ali ^a  

^a DICLE UNIVERSITY   (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^c State Hospital   (Turkey)

Author keywords

Albumin; Children; Chronic renal failure; Cytokines; Oxidative stress; Paraoxonase

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; C REACTIVE PROTEIN; CREATININE; CYTOKINE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZING AGENT; PEROXIDE; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; UREA; UREMIC TOXIN;

ADOLESCENT; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID OXIDATION; MALE; METABOLITE; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL ANALYSIS; UREMIA;

ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CHILD; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; OXIDATIVE STRESS; PEROXIDES;

EID: 30944459948     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2079-2     Document Type: Article

References (30)

1. Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356:147-152 10.1016/ S0140-6736(00)02456-9
2. Foley R, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 [Suppl]:S112-S119
3. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C (2003) Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant 18:1272-1280 10.1093/ndt/ gfg074
4. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T (2001) Endothelial dysfunction, oxidative stress and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:2673-2678 11723017
5. Diepeveen SHA, Verhoeven GH, van der Palen J, Dikkeschei B, van Tits LJ, Kolsters G, Offerman J, Bilo HJG, Stalenhoef AFH (2004) Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy. Nephron Clin Pract 98:c3-c7 10.1159/000079921
6. Annuk M, Fellstrom B, Akerblom O, Zilmer K, Vihalemm T, Zilmer M (2001) Oxidative stress markers in pre-uremic patients. Clin Nephrol 56:308-314 11680661
7. Nguyen-Khoa T, Massy ZA, DeBandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drueke TB, Lacour B, Thevenin M (2001) Oxidative stress and hemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16:335-340 10.1093/ndt/16.2.335
8. Mackness MI, Mackness B, Durrington PN, Connely PW, Hegele RA (1996) Paraoxonase: Biochemistry, genetics and relationship to plasma proteins. Curr Opin Lipidol 7:69-76 8743898
9. Dirican M, Akca R, Sarandol E, Dilek K (2004) Serum paraoxonase activity in uremic predialysis and hemodialysis patients. J Nephrol 17:813-818 15593056
10. Sutherland WH, de Jong SA, Walker RJ (2004) Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: An in vitro study. Nephrol Dial Transplant 19:75-82 10.1093/ndt/gfg484
11. Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, Leroux RC (1998) Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9:2082-2088 9808094
12. Massy ZA, Nguyen-Khoa T (2002) Oxidative stress and chronic renal failure: Markers and management. J Nephrol 15:336-341 12243361
13. Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112-119 10.1016/j.clinbiochem.2003.10.014
14. Harma M, Harma M, Erel O (2003) Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 133:563-566 14691728
15. Yanik M, Erel O, Kati M (2004) The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatr 16:200-203 10.1111/j.0924-2708.2004.00090.x
16. Harma M, Harma M, Erel O (2005) Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 10; 118:47-51
17. Furlong CE, Richter RJ, Seidel SL, Costa LG, Matulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/ arylesterase. Anal Biochem 180:242-247 10.1016/0003-2697(89)90424-7
18. Miyazawa T (1989) Determination of phospholipids hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med 7:209-217 10.1016/0891-5849(89)90017-8
19. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic renal disease. Kidney Int 65:1009-1016 10.1111/j.1523-1755.2004.00465.x
20. Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A (2005) Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artif Organs 29: 67-72 10.1111/j.1525-1594.2004.29011.x
21. Zwolinska D, Grzeszczak W, Kilis-Pstrusinska K, Szprynger K, Szczepanska M (2004) Lipid peroxidation and antioxidant enzymes in children with chronic renal failure. Pediatr Nephrol 19: 888-892 15179570
22. Sommerburg O, Grune T, Ehrich JH, Siems WG (2002) Adaptation of glutathione-peroxidase activity to oxidative stress occurs in children but not in adult patients with end-stage renal failure undergoing hemodialysis. Clin Nephrol 58 [Suppl 1]:S31-S36
23. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658 10.1046/j.1523-1755.1999.00273.x
24. Durak I, Kacmaz M, Elgun S, Ozturk HS (2004) Oxidative stress in patients with chronic renal failure: Effects of hemodialysis. Med Princ Pract 13:84-87 10.1159/000075634
25. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M (2005) IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int 67:1226-1233
26. Noh H, Lee SW, Kang SW, Shin SK, Chol KH, Lee HY, Han DS (1998) Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18:387-394 10505560
27. Panichi V, Migliori M, DePietro S, Taccola D, Bianchi AM, Giovannini L, Norpoth M, Metelli MR, Cristofani R, Bertelli A, Sbragia G, Tetta C, Palla R (2002) C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron 91:594-600 10.1159/000065018
28. Himmelfarb J, McMonagle E (2001) Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60:358-363 10.1046/ j.1523-1755.2001.00807.x
29. Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, Mackness M (2003) Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 107:2775-2779 10.1161/ 01.CIR.0000070954.00271.13
30. Gordon CA, Himmelfarb J (2004) Antioxidant therapy in uremia: evidence-based medicine? Semin Dial 17:327-332 10.1111/ j.0894-0959.2004.17357.x